IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 63 filers reported holding IGM BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $283,250 | -9.1% | 41,230 | +27.6% | 0.00% | – |
Q1 2024 | $311,695 | +16.1% | 32,300 | 0.0% | 0.00% | – |
Q4 2023 | $268,413 | -9.1% | 32,300 | -8.7% | 0.00% | – |
Q3 2023 | $295,256 | -2.4% | 35,360 | +7.9% | 0.00% | – |
Q2 2023 | $302,467 | -15.0% | 32,770 | +26.5% | 0.00% | – |
Q1 2023 | $355,866 | -19.2% | 25,900 | 0.0% | 0.00% | – |
Q4 2022 | $440,559 | -20.2% | 25,900 | +6.6% | 0.00% | – |
Q3 2022 | $552,000 | +22.9% | 24,296 | -2.4% | 0.00% | – |
Q2 2022 | $449,000 | +12.0% | 24,900 | +66.0% | 0.00% | – |
Q1 2022 | $401,000 | -8.9% | 15,000 | 0.0% | 0.00% | – |
Q4 2021 | $440,000 | -55.4% | 15,000 | 0.0% | 0.00% | – |
Q3 2021 | $986,000 | -23.6% | 15,000 | -3.2% | 0.00% | -100.0% |
Q2 2021 | $1,290,000 | +40.2% | 15,500 | +29.2% | 0.00% | – |
Q1 2021 | $920,000 | -19.9% | 12,000 | -7.7% | 0.00% | -100.0% |
Q4 2020 | $1,148,000 | +18.7% | 13,000 | -0.8% | 0.00% | 0.0% |
Q3 2020 | $967,000 | +20.4% | 13,100 | +19.1% | 0.00% | – |
Q2 2020 | $803,000 | +72.3% | 11,000 | +32.5% | 0.00% | – |
Q1 2020 | $466,000 | – | 8,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,425,455 | $252,833,000 | 4.64% |
Ikarian Capital, LLC | 313,300 | $23,124,000 | 1.67% |
Ikarian Capital, LLC | 250,000 | $18,452,000 | 1.34% |
RA Capital Management | 982,723 | $72,535,000 | 1.33% |
Artal Group S.A. | 688,910 | $50,848,000 | 1.23% |
Baker Brothers Advisors | 3,144,446 | $232,092,000 | 0.93% |
Cormorant Asset Management, LP | 225,000 | $16,607,000 | 0.64% |
MOODY ALDRICH PARTNERS LLC | 37,737 | $2,785,000 | 0.58% |
HighVista Strategies LLC | 9,417 | $695,000 | 0.51% |
Vivo Capital, LLC | 103,480 | $7,638,000 | 0.44% |